Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
Showing 9,541 - 9,560 results of 32,532 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( e point decrease ))', query time: 0.99s Refine Results
  1. 9541
    Table_5_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.xlsx

    Table_5_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
    Save to List
    Saved in:
  2. 9542
    Table_4_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.xlsx

    Table_4_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
    Save to List
    Saved in:
  3. 9543
    DataSheet_1_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.docx

    DataSheet_1_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasophary... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
    Save to List
    Saved in:
  4. 9544
    Table_3_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.xlsx

    Table_3_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
    Save to List
    Saved in:
  5. 9545
    Table_1_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.xlsx

    Table_1_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
    Save to List
    Saved in:
  6. 9546
    Table_2_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma.xlsx

    Table_2_Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngea... by Siqi Tang (3998222)

    Published 2023
    “…The KIF18B high expression group exhibited a higher TIDE score and elevated IC50 values for the commonly used chemotherapy drugs, gemcitabine, oxaliplatin, and 5-fluorouracil.…”
    Save to List
    Saved in:
  7. 9547
    Impingement area at the anteroinferior femoral neck in relation to different femoral versions and degrees of hip flexion.

    Impingement area at the anteroinferior femoral neck in relation to different femoral versions and degrees of hip flexion. by Jonathan Bourget-Murray (10884942)

    Published 2021
    Save to List
    Saved in:
  8. 9548
    DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx

    DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…A decrease in OS was found in IKZF1<sup>MUT</sup> and CDKN2A/2B<sup>MUT</sup> patients, but the significance was lost after IKZF1<sup>plus</sup> was removed.…”
    Save to List
    Saved in:
  9. 9549
    DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx

    DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…A decrease in OS was found in IKZF1<sup>MUT</sup> and CDKN2A/2B<sup>MUT</sup> patients, but the significance was lost after IKZF1<sup>plus</sup> was removed.…”
    Save to List
    Saved in:
  10. 9550
    Cyclic fatigue test block.

    Cyclic fatigue test block. by Beliz Özel (16475132)

    Published 2024
    Save to List
    Saved in:
  11. 9551
    GFP localization and expression in wild-type and <i>tbc-2</i> mutants.

    GFP localization and expression in wild-type and <i>tbc-2</i> mutants. by İçten Meraş (13184380)

    Published 2022
    Save to List
    Saved in:
  12. 9552
    Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes

    Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes by Pavel Štarha (490367)

    Published 2016
    “…Complexes showed high <i>in vitro</i> cytotoxicity against nine human cancer cell lines (IC<sub>50</sub> ranging from 0.4 to 12.8 μM), including the <i>cisplatin</i>-resistant ovarian cancer cell line (A2780R; IC<sub>50</sub> = 1.0–3.5 μM). …”
    Save to List
    Saved in:
  13. 9553
    Binding of nucleotide and compound 1 to yeast F<sub>1</sub> α- and β-subunits.

    Binding of nucleotide and compound 1 to yeast F<sub>1</sub> α- and β-subunits. by Lindsay B. Tulloch (1266861)

    Published 2017
    Save to List
    Saved in:
  14. 9554
    B-THP-Ts bind to C-terminal GFP-PTP tagged F<sub>1</sub> α- and β- subunits.

    B-THP-Ts bind to C-terminal GFP-PTP tagged F<sub>1</sub> α- and β- subunits. by Lindsay B. Tulloch (1266861)

    Published 2017
    Save to List
    Saved in:
  15. 9555
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Save to List
    Saved in:
  16. 9556
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Save to List
    Saved in:
  17. 9557
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Save to List
    Saved in:
  18. 9558
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Save to List
    Saved in:
  19. 9559
    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson’s Disease

    2‑(Fluoromethoxy)-4′‑(<i>S</i>‑methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for... by Javier García-Cárceles (2073898)

    Published 2022
    Save to List
    Saved in:
  20. 9560
    Effects of compounds on mitochondrial membrane potential.

    Effects of compounds on mitochondrial membrane potential. by Lindsay B. Tulloch (1266861)

    Published 2017
    Save to List
    Saved in:

Search Tools: